nice recent financial performance - worth a look as appears cheap compared with peers. High operating margins (38% pre tax) and eps growth (up 35% on pcp) and reasonable revenue growth.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025
